Published Oct 29, 2026, 8:23 PM ET · Updated 14 days ago · 2 sources

Dermatology Biotech Bambusa Raises $168.9 Million in US IPO

bloomberg

Original Report

Bambusa Therapeutics Inc., an early-stage biotech focused on dermatology and autoimmune diseases, raised $168.9 million in an upsized US initial public offering that priced at the midpoint of its marketed range.